Magic

[bobkubecka]

digiMedical Solutions, Inc. Issues Update on Projected $8.5 Million in Revenue for 2006
digiMedical Solutions, Inc. (OTC:DGMS) today issued an update on the Company's expected $8.5 million in revenue for 2006 in a Letter to Shareholders from CEO David Lee. The shareholder letter released today and included in its entirety below provides additional detail on the company's business plan and the company's plans for 2007.

Dear Fellow Shareholders and Interested Investors,

As I sit here, looking back over the past year and preparing for the future, I cannot help thinking how far this company has come over such a short time. Just 24 months ago, I founded digiMedical Solutions, Inc. with a vision of creating a company that would capitalize on the merging of the pharmaceutical and technology industries into a whole new digital prescription handling industry.

We have already seen significant growth to over $8.5 million in annual revenue in the short time since we founded the company. Now that we have completed our reverse merger, we are positioned to expand even more.

The purpose of this letter is to summarize our recent reverse merger, the overall market opportunity, our vision and progress to date, and our next steps as we head into 2007.

Reverse Merger with Game Technologies, Inc.

digiMedical Solutions, Inc. completed a reverse merger with Game Technologies, Inc. in June of this year. We subsequently changed the name of the company to digiMedical Solutions, Inc. and changed the ticker symbol to DGMS.

$82 Billion Market Opportunity

The overall Pharmacy industry is estimated at $277 billion, with a 8.5% annual growth rate. The Independent Pharmacy Chain segment of the overall Pharmacy industry makes up approximately $82 billion of the total $277 billion, with an estimate growth rate of about $23 billion annually. The Pharmacy Chains, like Walgreens (NYSE:WAG) and CVS (NYSE:CVS) do not operate in this space and are not considered competition.

We are leveraging our technology to streamline prescription fulfillment in the Independent Pharmacy Chain market segment in order to capitalize on that $82 billion market opportunity.

We have already seen significant growth and plan to continue by being a leader in this new industry. Currently, the Independent Pharmacy Chain market segment has very little competition, giving digiMedical a "head start" in the industry.

Our Business Plan and How it Works

Our focus is on the digital prescription handling portion of the new pharmacy/technology industry. With handwritten errors on the rise, loss of prescriptions, lack of timely processing of prescriptions and verifying patients information, our business model streamlines and improves the prescription handing process, from start to finish.

We do this by rolling out our own proprietary software, a product we named digiRX(TM). digiRX(TM) is a digital actuate medical management system that connects doctors, patients and pharmacist so that each have a pre-established relationship with the other. This gives the doctor confidence in the prescription process, and the pharmacist the confidence in the prescription. The patient benefits simply by the fact that neither the doctor nor the pharmacist need to verify the prescriptions thus getting their medication fast and efficiently.

Simply put, the patient's prescription is already waiting for them at the pharmacy when they leave the doctor's office. This process is extremely successful and repeatable. With this high level of service and convenience, our network of doctors and patients is growing rapidly. Our company profits come from changing both the doctor's and the patient's fulfillment habits by coming to our pharmacy.

So by now you must be asking "Does this work?" The answer is YES.

We already have four pharmacies in south Florida and two in Dallas, Texas where we have started the process of connecting the doctors and patients via digiRX(TM) to the pharmacies. We have over 30 prescribing users and over 35,000 patients that have access to our pharmacies.

2006 Wrap Up and Outlook for 2007

As we wrap up the year, we continue to work toward coming up to date on our financials and SEC filings. Our immediate goal is to become compliant and move to the OTCBB.

We are reviewing our financials now and forecast $8.5 million in reoccurring revenue (June through December) for 2006 and currently project "Same Store" revenues for full year 2007 exceeding $21.0 million in total revenue.

In 2007, we are planning to continue to grow our business with two additional acquisitions that would total over $24 million additional annualized revenue taking the company's total annualized revenue to over $45 million.

In closing, digiMedical's objective is to deliver on our vision by continuing to successfully acquire pharmacies in our target regions, to streamline them and gain operational efficiencies, and to expand our prescription services by adding more doctors and patients to our digiRX(TM) product. With our recent reverse merger and entry into the public market, we are excited and ready to grow our business and share its vision with both our current and future shareholders.

On behalf of all of us at digiMedical, thank you again for your ongoing interest and support of our company. Please look for more announcements on our progress in the near future.

Sincerely,

David Lee

CEO of digiMedical Solutions, Inc.

About digiMedical Solutions, Inc. (TM)

digiMedical Solutions, Inc.(TM) (http://www.digimsinc.com) is a pharmacy and medical technology company focused on developing next generation digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that will more closely align the doctor, pharmacist and patient. The company's planned growth will come from three channels: direct marketing of the company's wireless base d-prescription technology to doctors, acquisition of independent pharmacy chains and the sale of certain territories to "market partners" licensed to exploit the digiMedical Solutions(TM) model. digiMedical Solutions, Inc.(TM) currently owns and operates six (6) pharmacies located in Texas and Florida. digiMedical Solutions(TM)' unique business model brings doctor, patients and pharmacies into next generation medical technologies.

Forward-Looking Statement

Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission for additional information and a presentation of the risks and uncertainties that may affect the company's business and results of operations.


digiMedical Solutions, Inc.(TM)
David Lee, 817-503-8880
CEO
[e-mail]
or
Investor Relations, 214-722-3069
[e-mail]



Source: Business Wire (December 13, 2006 - 11:32 AM EST)

News by QuoteMedia